According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...
PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...
The company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...
AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality ...
PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points PHC has ...
GlobalData on MSN10d
Rentschler closes UK cell and gene therapy facility and does a pivot to biologicsCDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...
Sales of the firm's cell therapy franchise grew modestly in the fourth quarter amid competing product launches and overall slow uptake within the class.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback